{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:22:41Z","timestamp":1782973361486,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201831-10"],"award-info":[{"award-number":["201831-10"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00506"],"award-info":[{"award-number":["PI15\/00506"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red- Enfermedades Respiratorias","award":["CB06\/06\/0028"],"award-info":[{"award-number":["CB06\/06\/0028"]}]},{"name":"Quality Research group Generalitat de Catalunya","award":["SGR\/944"],"award-info":[{"award-number":["SGR\/944"]}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","award":["ICREA Academia 2019"],"award-info":[{"award-number":["ICREA Academia 2019"]}],"id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["LCF\/PR\/HR19\/52160019"],"award-info":[{"award-number":["LCF\/PR\/HR19\/52160019"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","award":["847462"],"award-info":[{"award-number":["847462"]}],"id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","award":["806\/2018"],"award-info":[{"award-number":["806\/2018"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022335","name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Universitat de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022335","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Streptococcus pneumoniae<\/jats:italic>, a primary cause of community-acquired pneumonia (CAP), is typically treated with \u03b2-lactams and macrolides or quinolones. Corticosteroids are now recommended as adjunctive therapy in severe CAP to improve outcomes. <jats:bold>I<\/jats:bold>n this prospective randomized animal study, we evaluated the bactericidal efficacy of various antibiotic regimens combined with corticosteroids using a porcine pneumococcal pneumonia model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In 30 White-Landrace female pigs, pneumonia was induced by intrabronchial inoculation of macrolide-resistant <jats:italic>S. pneumoniae<\/jats:italic> 19A isolate. Animals were randomized to receive saline, ceftriaxone (CRO) with levofloxacin (LVX), CRO with azithromycin (AZM), or combinations of these with methylprednisolone (MP). The primary outcome, <jats:italic>S. pneumoniae<\/jats:italic> concentrations in lung tissue after 48\u00a0h of treatment, showed that the CRO\u2009+\u2009LVX, CRO\u2009+\u2009AZM, CRO\u2009+\u2009LVX\u2009+\u2009MP, and CRO\u2009+\u2009AZM\u2009+\u2009MP groups were equally effective in reducing bacterial load. However, complete bacterial eradication from lung tissue was achieved only in the CRO\u2009+\u2009AZM\u2009+\u2009MP group. Secondary outcomes, including bacterial burden in tracheal aspirates and bronchoalveolar lavage (BAL) samples, showed similar bactericidal activity across all treatment groups. The CRO\u2009+\u2009AZM\u2009+\u2009MP group demonstrated the most controlled inflammatory response, achieving baseline levels of inflammation, while other groups exhibited elevated inflammatory markers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite using a macrolide-resistant <jats:italic>S. pneumoniae<\/jats:italic> isolate, the combination of CRO, AZM, and MP achieves similar or even superior results compared to other antibiotic combinations. This regimen provides both bactericidal and immunomodulatory benefits, suggesting its effectiveness in treating macrolide-resistant <jats:italic>S. pneumoniae<\/jats:italic> pneumonia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40635-025-00731-1","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:41:31Z","timestamp":1740681691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Corticosteroid and antimicrobial therapy in macrolide-resistant pneumococcal pneumonia porcine model"],"prefix":"10.1186","volume":"13","author":[{"given":"Ana","family":"Motos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Battaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Bobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Tanzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Rosa","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Arrieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Llonch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nona","family":"Rovira-Ribalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Barbeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"di Giannatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Nogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Fern\u00e1ndez-Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rigol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Kiarostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mart\u00edn-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi Li","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8643-2167","authenticated-orcid":false,"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"731_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"Collaborators GBDLRI","year":"2018","unstructured":"Collaborators GBDLRI (2018) Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global burden of disease study 2016. Lancet Infect Dis 18:1191\u20131210","journal-title":"Lancet Infect Dis"},{"key":"731_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71\u201379","journal-title":"Thorax"},{"key":"731_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1183\/09031936.00105513","volume":"42","author":"GJ Gibson","year":"2013","unstructured":"Gibson GJ, Loddenkemper R, Lundback B, Sibille Y (2013) Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J 42:559\u2013563","journal-title":"Eur Respir J"},{"key":"731_CR4","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1186\/cc13812","volume":"18","author":"AP Walden","year":"2014","unstructured":"Walden AP, Clarke GM, McKechnie S, Hutton P, Gordon AC, Rello J, Chiche JD, Stueber F, Garrard CS, Hinds CJ, Investigators EEG (2014) Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Crit Care 18:R58","journal-title":"Crit Care"},{"key":"731_CR5","doi-asserted-by":"publisher","first-page":"2200735","DOI":"10.1183\/13993003.00735-2022","volume":"61","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M, Bos L, Chalmers JD, Derde L, de Waele J, Garnacho-Montero J, Kollef M, Luna C, Menendez R, Niederman M, Ponomarev D, Restrepo M, Rigau D, Schultz MJ, Weiss E, Welte T, Wunderink R (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J 61:2200735","journal-title":"Eur Respir J"},{"key":"731_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","volume":"12","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, Doulou S, Kakavoulis N, Tsiakos K, Katopodis S, Schinas G, Skorda L, Alexiou Z, Armenis K, Katsaounou P, Chrysos G, Masgala A, Poulakou G, Antonakos N, Safarika A, Kyprianou M, Dakou K, Gerakari S, Papanikolaou IC, Milionis H, Marangos M, Dalekos GN, Tzavara V, Akinosoglou K, Hatziaggelaki E, Sympardi S, Kontopoulou T, Mouktaroudi M, Papadopoulos A, Niederman MS (2024) Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 12:294\u2013304","journal-title":"Lancet Respir Med"},{"key":"731_CR7","doi-asserted-by":"publisher","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R (2017) International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 50:1700582","journal-title":"Eur Respir J"},{"key":"731_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1183\/09031936.00040710","volume":"37","author":"R Martinez","year":"2011","unstructured":"Martinez R, Menendez R, Reyes S, Polverino E, Cilloniz C, Martinez A, Esquinas C, Filella X, Ramirez P, Torres A (2011) Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. Eur Respir J 37:393\u2013399","journal-title":"Eur Respir J"},{"key":"731_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1128\/CVI.00423-12","volume":"19","author":"HH Remmelts","year":"2012","unstructured":"Remmelts HH, Meijvis SC, Biesma DH, van Velzen-Blad H, Voorn GP, Grutters JC, Bos WJ, Rijkers GT (2012) Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia. Clin Vaccine Immunol 19:1532\u20131538","journal-title":"Clin Vaccine Immunol"},{"key":"731_CR10","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","volume":"385","author":"CA Blum","year":"2015","unstructured":"Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M (2015) Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 385:1511\u20131518","journal-title":"Lancet"},{"key":"731_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrus A, Sellares J, Restrepo MI, Anzueto A, Niederman MS, Agusti C (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677\u2013686","journal-title":"JAMA"},{"key":"731_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"PF Dequin","year":"2023","unstructured":"Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefeve G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, Francois B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L\u2019Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengelle C, Caille-Fenerol C, Giraudeau B, Le Gouge A, Network CR-T (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388:1931\u20131941","journal-title":"N Engl J Med"},{"key":"731_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, Billot L, Correa M, Glass P, Harward M, Joyce C, Li Q, McArthur C, Perner A, Rhodes A, Thompson K, Webb S, Myburgh J, Investigators AT, the Australian-New Zealand Intensive Care Society Clinical Trials G (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 378:797\u2013808","journal-title":"N Engl J Med"},{"key":"731_CR14","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1186\/cc9044","volume":"14","author":"R Beale","year":"2010","unstructured":"Beale R, Janes JM, Brunkhorst FM, Dobb G, Levy MM, Martin GS, Ramsay G, Silva E, Sprung CL, Vallet B, Vincent JL, Costigan TM, Leishman AG, Williams MD, Reinhart K (2010) Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care 14:R102","journal-title":"Crit Care"},{"key":"731_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11908-013-0322-8","volume":"15","author":"M Confalonieri","year":"2013","unstructured":"Confalonieri M, Annane D, Antonaglia C, Santagiuliana M, Borriello EM, Meduri GU (2013) Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep 15:158\u2013166","journal-title":"Curr Infect Dis Rep"},{"key":"731_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcrc.2010.07.014","volume":"26","author":"JI Salluh","year":"2011","unstructured":"Salluh JI, Soares M, Coelho LM, Bozza FA, Verdeal JC, Castro-Faria-Neto HC, e Silva JR, Bozza PT, Povoa P (2011) Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care 26:193\u2013200","journal-title":"J Crit Care"},{"key":"731_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41684-021-00876-y","volume":"50","author":"R Amaro","year":"2021","unstructured":"Amaro R, Li Bassi G, Motos A, Fernandez-Barat L, Aguilera Xiol E, Rigol M, Frigola G, Travierso C, Bobi J, Pagliara F, Carbonara M, Comaru T, Chiurazzi C, Yang M, Yang H, Arrieta M, Marti JD, De Rosa F, Saco MA, Rinaudo M, Terraneo S, Schultz MJ, Nicolau DP, Artigas A, Ramirez J, Torres A (2021) Development and characterization of a new swine model of invasive pneumococcal pneumonia. Lab Anim 50:327\u2013335","journal-title":"Lab Anim"},{"key":"731_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1128\/JCM.01454-08","volume":"47","author":"A Fenoll","year":"2009","unstructured":"Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarrago D (2009) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47:1012\u20131020","journal-title":"J Clin Microbiol"},{"key":"731_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/ALN.0000000000000222","volume":"120","author":"G Li Bassi","year":"2014","unstructured":"Li Bassi G, Rigol M, Marti JD, Saucedo L, Ranzani OT, Roca I, Cabanas M, Munoz L, Giunta V, Luque N, Rinaudo M, Esperatti M, Fernandez-Barat L, Ferrer M, Vila J, Ramirez J, Torres A (2014) A novel porcine model of ventilator-associated pneumonia caused by oropharyngeal challenge with Pseudomonas aeruginosa. Anesthesiology 120:1205\u20131215","journal-title":"Anesthesiology"},{"key":"731_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM, Acute Lung Injury in Animals Study G (2011) An official American thoracic society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44:725\u2013738","journal-title":"Am J Respir Cell Mol Biol"},{"key":"731_CR21","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1164\/ajrccm.151.6.7767535","volume":"151","author":"CH Marquette","year":"1995","unstructured":"Marquette CH, Copin MC, Wallet F, Neviere R, Saulnier F, Mathieu D, Durocher A, Ramon P, Tonnel AB (1995) Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 151:1878\u20131888","journal-title":"Am J Respir Crit Care Med"},{"key":"731_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1165\/rcmb.2022-0068LE","volume":"67","author":"LR Schouten","year":"2022","unstructured":"Schouten LR, Vlaar APJ, Bos LDJ, Bem RA (2022) Experimental acute lung injury in animals: with age comes knowledge. Am J Respir Cell Mol Biol 67:266","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"60","key":"731_CR23","first-page":"532","volume":"1986","author":"SI Rennard","year":"1985","unstructured":"Rennard SI, Basset G, Lecossier D, O\u2019Donnell KM, Pinkston P, Martin PG, Crystal RG (1985) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986(60):532\u2013538","journal-title":"J Appl Physiol"},{"key":"731_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1183\/09031936.00176709","volume":"36","author":"P Martinez-Olondris","year":"2010","unstructured":"Martinez-Olondris P, Sibila O, Agusti C, Rigol M, Soy D, Esquinas C, Piner R, Luque N, Guerrero L, Quera MA, Marco F, de la Bellacasa JP, Ramirez J, Torres A (2010) An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets. Eur Respir J 36:901\u2013906","journal-title":"Eur Respir J"},{"key":"731_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1183\/09031936.00054108","volume":"33","author":"MI Restrepo","year":"2009","unstructured":"Restrepo MI, Mortensen EM, Waterer GW, Wunderink RG, Coalson JJ, Anzueto A (2009) Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Respir J 33:153\u2013159","journal-title":"Eur Respir J"},{"key":"731_CR26","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","volume":"36","author":"I Martin-Loeches","year":"2010","unstructured":"Martin-Loeches I, Lisboa T, Rodriguez A, Putensen C, Annane D, Garnacho-Montero J, Restrepo MI, Rello J (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36:612\u2013620","journal-title":"Intensive Care Med"},{"issue":"Suppl 2","key":"731_CR27","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG, Infectious Diseases Society of A, American Thoracic S (2007) Infectious diseases society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-72","journal-title":"Clin Infect Dis"},{"key":"731_CR28","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/AAC.49.3.1225-1228.2005","volume":"49","author":"S Djurkovic","year":"2005","unstructured":"Djurkovic S, Loeffler JM, Fischetti VA (2005) Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrob Agents Chemother 49:1225\u20131228","journal-title":"Antimicrob Agents Chemother"},{"key":"731_CR29","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1128\/AAC.00006-07","volume":"51","author":"TP Lodise","year":"2007","unstructured":"Lodise TP, Kwa A, Cosler L, Gupta R, Smith RP (2007) Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia. Antimicrob Agents Chemother 51:3977\u20133982","journal-title":"Antimicrob Agents Chemother"},{"key":"731_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK (2010) Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev 23:590\u2013615","journal-title":"Clin Microbiol Rev"},{"key":"731_CR31","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1086\/315861","volume":"182","author":"KL Orman","year":"2000","unstructured":"Orman KL, English BK (2000) Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae. J Infect Dis 182:1561\u20131565","journal-title":"J Infect Dis"},{"key":"731_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/jac\/dkr520","volume":"67","author":"A Kovaleva","year":"2012","unstructured":"Kovaleva A, Remmelts HH, Rijkers GT, Hoepelman AI, Biesma DH, Oosterheert JJ (2012) Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review. J Antimicrob Chemother 67:530\u2013540","journal-title":"J Antimicrob Chemother"},{"key":"731_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.resinv.2015.05.003","volume":"53","author":"M Emmet O'Brien","year":"2015","unstructured":"Emmet O\u2019Brien M, Restrepo MI, Martin-Loeches I (2015) Update on the combination effect of macrolide antibiotics in community-acquired pneumonia. Respir Investig 53:201\u2013209","journal-title":"Respir Investig"},{"key":"731_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.qco.0000160901.71813.fe","volume":"18","author":"MJ Parnham","year":"2005","unstructured":"Parnham MJ (2005) Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr Opin Infect Dis 18:125\u2013131","journal-title":"Curr Opin Infect Dis"},{"key":"731_CR35","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, Carcillo JA, Correa R, Drover K, Esper AM, Gershengorn HB, Hammond NE, Jayaprakash N, Menon K, Nazer L, Pitre T, Qasim ZA, Russell JA, Santos AP, Sarwal A, Spencer-Segal J, Tilouche N, Annane D, Pastores SM (2024) 2024 Focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia. Crit Care Med 52:e219\u2013e233","journal-title":"Crit Care Med"},{"key":"731_CR36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335:2\u201313","journal-title":"Mol Cell Endocrinol"},{"key":"731_CR37","first-page":"CD007720","volume":"12","author":"A Stern","year":"2017","unstructured":"Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M (2017) Corticosteroids for pneumonia. Cochrane Database Syst Rev 12:CD007720","journal-title":"Cochrane Database Syst Rev"},{"key":"731_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1939-1676.1991.tb00939.x","volume":"5","author":"LA Cohn","year":"1991","unstructured":"Cohn LA (1991) The influence of corticosteroids on host defense mechanisms. J Vet Intern Med 5:95\u2013104","journal-title":"J Vet Intern Med"},{"key":"731_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178022","volume":"12","author":"A Ceccato","year":"2017","unstructured":"Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A (2017) Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: a post-hoc exploratory analysis of a randomized controlled trial. PLoS ONE 12:e0178022","journal-title":"PLoS ONE"},{"key":"731_CR40","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/0192623312470763","volume":"41","author":"E Wahlstrom","year":"2013","unstructured":"Wahlstrom E, Ollerstam A, Sundius L, Zhang H (2013) Use of lung weight as biomarker for assessment of lung toxicity in rat inhalation studies. Toxicol Pathol 41:902\u2013912","journal-title":"Toxicol Pathol"},{"key":"731_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/1348-9585.12162","volume":"62","author":"KI Nishi","year":"2020","unstructured":"Nishi KI, Kadoya C, Ogami A, Oyabu T, Morimoto Y, Ueno S, Myojo T (2020) Changes over time in pulmonary inflammatory response in rat lungs after intratracheal instillation of nickel oxide nanoparticles. J Occup Health 62:e12162","journal-title":"J Occup Health"},{"key":"731_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4049\/jimmunol.168.1.372","volume":"168","author":"FN Lauw","year":"2002","unstructured":"Lauw FN, Branger J, Florquin S, Speelman P, van Deventer SJ, Akira S, van der Poll T (2002) IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 168:372\u2013378","journal-title":"J Immunol"},{"key":"731_CR43","first-page":"73","volume":"526","author":"J Vaage","year":"1985","unstructured":"Vaage J (1985) Effects of high-dose corticosteroids on the pulmonary circulation. Acta Chir Scand Suppl 526:73\u201382","journal-title":"Acta Chir Scand Suppl"},{"key":"731_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13054-024-04956-6","volume":"28","author":"H Taenaka","year":"2024","unstructured":"Taenaka H, Wick KD, Sarma A, Matsumoto S, Ghale R, Fang X, Maishan M, Gotts JE, Langelier CR, Calfee CS, Matthay MA (2024) Biological effects of corticosteroids on pneumococcal pneumonia in Mice-translational significance. Crit Care 28:185","journal-title":"Crit Care"},{"key":"731_CR45","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1183\/09031936.00009208","volume":"32","author":"O Sibila","year":"2008","unstructured":"Sibila O, Luna CM, Agusti C, Baquero S, Gando S, Patron JR, Morato JG, Absi R, Bassi N, Torres A (2008) Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J 32:1037\u20131046","journal-title":"Eur Respir J"},{"key":"731_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","volume":"179","author":"F Fang","year":"2019","unstructured":"Fang F, Zhang Y, Tang J, Lunsford LD, Li T, Tang R, He J, Xu P, Faramand A, Xu J, You C (2019) Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA Intern Med 179:213\u2013223","journal-title":"JAMA Intern Med"},{"key":"731_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","volume":"20","author":"S Tongyoo","year":"2016","unstructured":"Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 20:329","journal-title":"Crit Care"},{"key":"731_CR48","doi-asserted-by":"publisher","first-page":"105836","DOI":"10.1016\/j.ijantimicag.2019.10.017","volume":"55","author":"E Kyriazopoulou","year":"2020","unstructured":"Kyriazopoulou E, Sinapidis D, Halvatzis S, Velissaris D, Alexiou N, Kosmas V, Adami ME, Kyprianou M, Kyprianou A, Stefos A, Lada M, Koutoukas P, Pavlaki M, Kyriakoudi A, Makina A, Gogos C, Niederman MS, Giamarellos-Bourboulis EJ (2020) Survival benefit associated with clarithromycin in severe community-acquired pneumonia: a matched comparator study. Int J Antimicrob Agents 55:105836","journal-title":"Int J Antimicrob Agents"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00731-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T18:41:39Z","timestamp":1740681699000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00731-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00731-1","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted at the University of Barcelona\u2019s animal facilities in Barcelona, Spain. The study protocol was approved by the Animal Experimentation Ethics Committee of the University of Barcelona (approval reference number: 06\/17). All procedures were conducted following the European Directive 2010\/63\/UE and Spanish RD 53\/2013 regulations related to the Guide for the Care and Use of Laboratory Animals and complied with the PREPARE and ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}